DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,998 | +5.3% | 108,817 | +1.8% | 0.50% | +9.4% |
| Q2 2023 | $25,650 | -19.9% | 106,879 | -15.8% | 0.46% | -25.0% |
| Q1 2023 | $32,015 | -8.2% | 126,931 | -3.4% | 0.61% | -11.4% |
| Q4 2022 | $34,892 | -99.9% | 131,458 | -6.4% | 0.69% | -7.2% |
| Q3 2022 | $36,279,000 | +4.9% | 140,457 | +3.0% | 0.74% | -6.3% |
| Q2 2022 | $34,576,000 | -17.8% | 136,383 | -4.3% | 0.79% | -4.1% |
| Q1 2022 | $42,086,000 | -12.4% | 142,513 | -2.4% | 0.82% | -9.2% |
| Q4 2021 | $48,051,000 | +7.6% | 146,044 | -0.5% | 0.91% | -1.8% |
| Q3 2021 | $44,676,000 | +125.5% | 146,743 | +98.8% | 0.92% | +94.5% |
| Q2 2021 | $19,813,000 | +16.6% | 73,829 | -2.2% | 0.48% | +8.2% |
| Q1 2021 | $16,999,000 | +4.8% | 75,518 | +3.4% | 0.44% | -9.5% |
| Q4 2020 | $16,228,000 | +3.2% | 73,052 | +0.0% | 0.48% | -15.1% |
| Q3 2020 | $15,726,000 | +24.4% | 73,032 | +2.2% | 0.57% | +14.2% |
| Q2 2020 | $12,637,000 | +31.0% | 71,463 | +2.6% | 0.50% | +9.9% |
| Q1 2020 | $9,644,000 | -13.0% | 69,682 | -3.5% | 0.46% | +2.0% |
| Q4 2019 | $11,085,000 | +5.3% | 72,221 | -0.9% | 0.45% | -1.3% |
| Q3 2019 | $10,526,000 | +1.7% | 72,877 | +0.6% | 0.45% | +0.7% |
| Q2 2019 | $10,354,000 | +10.3% | 72,444 | +1.9% | 0.45% | +5.9% |
| Q1 2019 | $9,388,000 | +77.0% | 71,112 | +38.3% | 0.42% | +56.5% |
| Q4 2018 | $5,303,000 | +3.4% | 51,423 | +9.0% | 0.27% | +8.4% |
| Q3 2018 | $5,127,000 | +8.9% | 47,178 | -1.1% | 0.25% | +1.6% |
| Q2 2018 | $4,707,000 | -99.9% | 47,703 | -0.6% | 0.25% | -3.1% |
| Q1 2018 | $4,699,974,000 | +5.6% | 48,003 | +0.1% | 0.25% | +6.3% |
| Q4 2017 | $4,451,276,000 | +7.3% | 47,956 | -0.9% | 0.24% | +0.4% |
| Q3 2017 | $4,149,265,000 | -3.0% | 48,371 | -4.5% | 0.24% | -7.0% |
| Q2 2017 | $4,276,548,000 | -4.4% | 50,676 | -3.1% | 0.26% | -6.9% |
| Q1 2017 | $4,473,305,000 | +6.1% | 52,301 | -3.4% | 0.28% | +0.7% |
| Q4 2016 | $4,216,437,000 | +0.0% | 54,168 | +0.7% | 0.27% | -3.2% |
| Q3 2016 | $4,214,795,000 | -25.6% | 53,767 | -4.2% | 0.28% | -27.9% |
| Q2 2016 | $5,665,797,000 | +2.0% | 56,097 | -4.2% | 0.39% | +0.3% |
| Q1 2016 | $5,557,088,000 | -0.9% | 58,582 | -2.9% | 0.39% | -0.8% |
| Q4 2015 | $5,605,958,000 | +4.5% | 60,357 | -4.1% | 0.39% | -2.2% |
| Q3 2015 | $5,364,566,000 | -1.9% | 62,957 | -1.5% | 0.40% | +5.0% |
| Q2 2015 | $5,471,084,000 | -1.1% | 63,922 | -1.9% | 0.38% | 0.0% |
| Q1 2015 | $5,533,103,000 | -1.0% | 65,172 | -0.1% | 0.38% | -2.8% |
| Q4 2014 | $5,590,177,000 | +6.0% | 65,222 | -6.0% | 0.39% | 0.0% |
| Q3 2014 | $5,272,556,000 | -48.4% | 69,394 | -46.5% | 0.39% | -48.6% |
| Q2 2014 | $10,211,517,000 | +3.5% | 129,703 | -1.4% | 0.77% | -1.4% |
| Q1 2014 | $9,864,225,000 | -4.0% | 131,523 | -1.2% | 0.78% | -5.9% |
| Q4 2013 | $10,273,621,000 | +9.0% | 133,078 | -2.1% | 0.83% | -0.2% |
| Q3 2013 | $9,422,321,000 | +8.9% | 135,925 | -0.5% | 0.83% | +4.8% |
| Q2 2013 | $8,651,275,000 | – | 136,671 | – | 0.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |